Peterson Karen
Research Policy and Special Programs Branch, National Institute on Alcohol Abuse and Alcoholism's Office of Scientific Affairs, Bethesda, Maryland, USA.
Alcohol Res Health. 2004;28(1):30-7.
Clinicians can use several biochemical measurements to objectively assess patients' current or past alcohol use. However, none of these currently available biomarkers-including measures of various liver enzymes and blood volume--are ideal. Several more experimental markers hold promise for measuring acute alcohol consumption and relapse. These include certain alcohol byproducts, such as acetaldehyde, ethyl glucuronide (EtG), and fatty acid ethyl esters (FAEE), as well as two measures of sialic acid, a carbohydrate that appears to be altered in alcoholics. Some progress has been made in finding markers that predict people's genetic predisposition to alcoholism, such as genetic differences in several neurotransmitters, including beta-endorphin and gamma-aminobutryic acid (GABA).
临床医生可以使用多种生化检测方法来客观评估患者当前或过去的饮酒情况。然而,目前可用的这些生物标志物——包括各种肝酶和血容量的检测指标——都不理想。还有几种更具实验性的标志物有望用于测量急性酒精摄入量和复发情况。这些标志物包括某些酒精副产物,如乙醛、葡萄糖醛酸乙酯(EtG)和脂肪酸乙酯(FAEE),以及两种唾液酸检测指标,唾液酸是一种在酗酒者体内似乎会发生变化的碳水化合物。在寻找能够预测人们酗酒遗传易感性的标志物方面已经取得了一些进展,比如几种神经递质(包括β-内啡肽和γ-氨基丁酸(GABA))的基因差异。